Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL.
Nienke M A IdzerdaLindsay E CleggAdrian F HernandezGeorge L BakrisRobert C PenlandDavid W BoultonM Angelyn BethelRury R HolmanHiddo J Lambers HeerspinkPublished in: Diabetes, obesity & metabolism (2020)
Integrating short-term risk marker changes into a multivariable risk score predicted the magnitude of renal risk reduction observed in EXSCEL.
Keyphrases